Advertisement

Topics

STAT Plus: A Chinese billionaire may get a monopoly on a cancer drug backed by U.S. taxpayers

13:05 EDT 9 Aug 2017 | STAT

The NIH plans to award an exclusive license for medical technology that was funded by U.S. taxpayers to a company controlled by a Chinese billionaire.

Original Article: STAT Plus: A Chinese billionaire may get a monopoly on a cancer drug backed by U.S. taxpayers

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: A Chinese billionaire may get a monopoly on a cancer drug backed by U.S. taxpayers"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...